US equities |
SPCX $171.09 ▲+0.00% META $741.90 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% AMZN $251.40 ▲+0.00% AMD $631.75 ▲+0.00% STX $887.09 ▲+0.00% SNDK $1,704.16 ▲+0.00%
FinancialContent

Latest News about CaaMTech Inc/

Recent news which mentions CaaMTech Inc/

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Tickers CMPS NEWS
Tags Markets Food and Drug Administration (FDA) major depressive disorder
From Benzinga
Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments
Tickers NEWS
Tags Psychedelics Health Care Cannabis
From Benzinga
Exclusive: CaaMTech And Alexander Shulgin Research Institute To Follow Study On Shulgin's Compounds
Tags Cannabis the Alexander Shulgin Research Institute Inc/ Dr/ Nicholas Cozzi
From Benzinga